Hypertrophic cardiomyopathy (HCM) is one of the most frequently occurring i
nherited cardiac disorders, affecting up to 1 in 500 of the population. Mol
ecular genetic analysis has shown that HCM is a disease of the sarcomere, c
aused by mutations in certain contractile protein genes. To date seven dise
ase-associated genes have been identified, those encoding beta-myosin heavy
chain, both regulatory and essential myosin light chains, myosin binding p
rotein-C, cardiac troponin T, cardiac troponin I and alpha-tropomyosin. Her
e we review the analyses of how these mutations affect the in vitro contrac
tile protein function and the hypotheses derived to explain the development
of the disease state. (C) 1999 Elsevier Science B.V. All rights reserved.